Comparison of the therapeutic efficacy of chloroquine and sulphadoxine‐pyremethamine in children and pregnant women

Objective  To compare the parasitological failure rates of under‐fives and pregnant women with parasitaemia treated with chloroquine (CQ) or sulphadoxine‐pyrimethamine (SP).

[1]  C. Menéndez,et al.  Reducing the burden of malaria in pregnancy by preventive strategies. , 2007, The Lancet. Infectious diseases.

[2]  F. Nosten,et al.  Case management of malaria in pregnancy. , 2007, The Lancet. Infectious diseases.

[3]  D. Chandramohan,et al.  Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial , 2006, The Lancet.

[4]  B. Brabin,et al.  Comparative efficacy of chloroquine and sulphadoxine – pyrimethamine in pregnant women and children: a meta‐analysis , 2006, Tropical medicine & international health : TM & IH.

[5]  F. Checchi,et al.  Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine–pyrimethamine and amodiaquine , 2005, Tropical medicine & international health : TM & IH.

[6]  Nicholas J White,et al.  How do patients use antimalarial drugs? A review of the evidence , 2005, Tropical medicine & international health : TM & IH.

[7]  R. Snow,et al.  Therapy of Falciparum Malaria in Sub-Saharan Africa: from Molecule to Policy , 2004, Clinical Microbiology Reviews.

[8]  O. Traoré,et al.  Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. , 2003, The American journal of tropical medicine and hygiene.

[9]  P. Newton,et al.  Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Meshnick,et al.  Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. , 2003, The American journal of tropical medicine and hygiene.

[11]  R. Snow,et al.  Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria , 2003 .

[12]  M. Kamya,et al.  Increasing antimalarial drug resistance in Uganda and revision of the national drug policy , 2002, Tropical medicine & international health : TM & IH.

[13]  I. Bygbjerg,et al.  Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change of treatment policy , 2001, Tropical medicine & international health : TM & IH.

[14]  B. Karoumi,et al.  Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience , 2001, Tropical medicine & international health : TM & IH.

[15]  U. d’Alessandro,et al.  History and importance of antimalarial drug resistance , 2001, Tropical medicine & international health : TM & IH.

[16]  B. Karoumi,et al.  Vitamin therapy and prevention of neural tube defects , 2001 .

[17]  R. Snow,et al.  Using evidence to change antimalarial drug policy in Kenya , 2000, Tropical medicine & international health : TM & IH.

[18]  W. Jarra,et al.  Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  P. Bloland,et al.  Making malaria-treatment policy in the face of drug resistance. , 1999, Annals of tropical medicine and parasitology.

[20]  P. Bloland,et al.  A systematic approach to the development of a rational malaria treatment policy in Zambia , 1998, Tropical medicine & international health : TM & IH.

[21]  N. White.  Why is it that antimalarial drug treatments do not always work? , 1998, Annals of tropical medicine and parasitology.

[22]  R. Steketee.  A decade of progress in malaria policy and program development in Malawi; 1984-1993 , 1995 .

[23]  J. Breman,et al.  Formulation of malaria treatment policy for children in Côte d'Ivoire as chloroquine resistant Plasmodium falciparum spreads into west Africa. , 1989, Annals of Tropical Medicine and Parasitology.